Regarding the immunopathology and serological findings in pemphigus vulgaris, all of the following statements are true EXCEPT:

Explanation

## Immunopathology of Pemphigus Vulgaris **Key Point:** Direct immunofluorescence in pemphigus vulgaris shows **intercellular IgG and C3 deposition** within the epidermis, NOT linear deposits along the basement membrane zone. Linear BMZ deposits are characteristic of bullous pemphigoid and linear IgA disease. ### Correct Answer Analysis Option 3 is INCORRECT. Direct immunofluorescence (DIF) in pemphigus vulgaris demonstrates **intercellular (intraepidermal) IgG and C3 deposition** in an "intercellular bridge" or "tombstone" pattern around acantholytic keratinocytes. Linear deposits along the dermal-epidermal junction are NOT seen in pemphigus and would instead suggest pemphigoid or linear IgA disease. ### Comparison: DIF Patterns in Bullous Disorders | Disorder | DIF Pattern | Location | Antigen | |----------|-------------|----------|----------| | **Pemphigus vulgaris** | Intercellular IgG + C3 | Intraepidermal | Desmoglein 3 ± 1 | | **Bullous pemphigoid** | Linear IgG + C3 | Basement membrane zone | BP180, BP230 | | **Linear IgA disease** | Linear IgA | Basement membrane zone | Various epidermal antigens | | **Dermatitis herpetiformis** | Granular IgA | Dermal-epidermal junction | Tissue transglutaminase | **High-Yield:** The **intercellular pattern** in pemphigus is pathognomonic and distinguishes it from all other blistering disorders. This is a frequently tested concept. ### Why the Other Options Are Correct **Option 1 (Circulating antibodies and disease activity):** Serum anti-Dsg3 and anti-Dsg1 IgG titers correlate with disease severity and are used to monitor response to immunosuppressive therapy. Rising titers may precede clinical flares. **Option 2 (Indirect immunofluorescence):** Indirect immunofluorescence (IIF) on patient serum detects circulating IgG autoantibodies. When applied to normal human skin, these antibodies bind to the intercellular spaces of the epidermis in a characteristic "net-like" or "honeycomb" pattern — this is diagnostic and highly specific. **Option 4 (ELISA for desmoglein antibodies):** ELISA using recombinant desmoglein 3 and desmoglein 1 is a sensitive and specific method to detect and quantify anti-Dsg antibodies; it has become the gold standard for serological diagnosis and monitoring. ### Diagnostic Algorithm ```mermaid flowchart TD A[Clinical suspicion of pemphigus]:::outcome --> B[Skin biopsy for histopathology]:::action B --> C{Acantholysis present?}:::decision C -->|Yes| D[Direct immunofluorescence]:::action C -->|No| E[Consider other diagnosis]:::action D --> F{Intercellular IgG pattern?}:::decision F -->|Yes| G[Pemphigus likely]:::outcome F -->|No| H[Consider bullous pemphigoid<br/>or other disorder]:::outcome G --> I[Indirect IF or ELISA<br/>for desmoglein antibodies]:::action I --> J[Confirm diagnosis<br/>and assess severity]:::outcome ``` **Clinical Pearl:** A patient with positive DIF showing intercellular IgG but negative for linear BMZ deposits can be confidently diagnosed with pemphigus; serology (anti-Dsg antibodies) then confirms the type and severity. [cite:Robbins 10e Ch 25; Harrison 21e Ch 325]